Results 291 to 300 of about 77,075 (344)
PM-POCUS in Palliative OPDs: Bridging Home-Based Assessment and Hospital Expertise for Malignant Pleural Effusion Management in Advanced Cancer. [PDF]
Indian J Palliat CarePathari A +3 more
europepmc +1 more source
Exosomal miR-182-5p is a potential diagnostic marker for malignant pleural effusion. [PDF]
Transl Lung Cancer ResZhao W +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Seminars in Respiratory and Critical Care Medicine, 1985
Various diseases of the gastrointestinal tract at times are accompanied by an exudative pleural effusion. The exudative pleural effusions resulting from esophageal perforation, pancreatic disease, subphrenic abscess, intrahepatic abscess, splenic abscess, abdominal operations, and diaphragmatic hernia are discussed in this article.
B H, Gobel, P E, Lawler
openaire +5 more sources
Various diseases of the gastrointestinal tract at times are accompanied by an exudative pleural effusion. The exudative pleural effusions resulting from esophageal perforation, pancreatic disease, subphrenic abscess, intrahepatic abscess, splenic abscess, abdominal operations, and diaphragmatic hernia are discussed in this article.
B H, Gobel, P E, Lawler
openaire +5 more sources
Cancer Treatment Reviews, 1978
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
M A, Friedman, E, Slater
openaire +2 more sources
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
M A, Friedman, E, Slater
openaire +2 more sources
Phenotyping malignant pleural effusions
Current Opinion in Pulmonary Medicine, 2016Patients with malignant pleural effusions (MPEs) are heterogenous in their disease course, symptom severity, responses to cancer therapies, fluid recurrence rates, and thus need for definitive fluid control measures. To tailor the most appropriate treatment for individual patients, clinicians need to 'phenotype' the patients and predict their clinical ...
Macy M S, Lui +2 more
openaire +2 more sources
Pleural Effusion from Malignancy
Annals of Internal Medicine, 1978Pleural effusion from metastatic malignancy can cause major impairment of respiratory function and eventual death. Although cure is not possible, successful palliative treatment allows months to years of productive life, obviating the need for continuous hospitalization and repeated thoracenteses.
A, Leff, P C, Hopewell, J, Costello
openaire +2 more sources